MedTrace Logo

Predictive Value of the Global Limb Anatomic Staging System (GLASS) in Patients With Critical Limb-threatening Ischemia

NCT05999669 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-08-21

No results posted yet for this study

Summary

The Global Vascular Guideline on chronic limb threatening ischemia (CLTI) proposes the Global Limb Anatomic Staging System (GLASS), a new angiographic scoring system to quantify the anatomic severity of infrainguinal disease in CLTI patients. However, GLASS validation still needs to be completed, and the infrapopliteal (IP) target artery pathway (TAP) was easily influenced by the procedures. Thus the IP target artery could be selected either as the least diseased artery based on angiography or prospectively based on the angiosome concept. So the investigators aim to evaluate its correlation with clinical outcomes after revascularization.

Conditions

  • Peripheral Arterial Disease

Interventions

OTHER

GLASS staging

use the Global Limb Anatomic Staging System (GLASS) to evaluate its correlation with clinical outcomes after revascularization

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • Second Affiliated Hospital of Soochow University

    collaborator OTHER

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Qingdao Haici Hospital

    collaborator OTHER

  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Xiamen Cardiovascular Hospital, Xiamen University

    collaborator OTHER

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Meng Ye, M.D. · Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-20
Primary Completion
2026-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05999669 on ClinicalTrials.gov